Intrauterine nutrition;Intrauterin ernæring

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 20, 1998, Pages 3162-3165

  Henriksen, Tore ^a  

^a Universitetet i Oslo   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH WEIGHT; CHILD; CHILD DEVELOPMENT; FEMALE; FETOMATERNAL TRANSFUSION; FETUS DISEASE; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; NUTRITIONAL DISORDER; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; REVIEW; RISK FACTOR;

BIRTH WEIGHT; CHILD; CHILD DEVELOPMENT; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETAL DISEASES; FETAL GROWTH RETARDATION; HUMANS; INFANT; MATERNAL-FETAL EXCHANGE; NUTRITION DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 0032581783     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Leon DA. Fetal growth and adult disease. Eur J Clin Nutr 1998; 52 (suppl 1): 72-82.
2. Clarke SD, Abraham S. Gene expression: nutrient control of pré and posttranscriptional events. FASEB J 1992; 6: 3146-52.
3. Martorell R. Undernutrition during pregnancy and early childhood: consequences for cognitiv and behavioral development. I: Young EM, red. Early child development. Investing in our children's future. Amsterdam: Elsevier, 1997: 39-83.
4. Prentice AM, Popitt SD, Goldberg OR, Murgatroyd PR, Black AE, Coward WA. Energy balance in pregnancy and lactation. I: Allen L, King J, Lønnerdal B, red. Nutritional regulation during pregnancy, lactation, and infant growth. New York: Plenum Press, 1994: 11-26.
5. Ravelli ACJ, van der Meulen JHP, Michels RPJ, Osmond C, Barker DJP, Hales CN et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998; 351: 173-7.
6. Rothman KJ, Moore LL, Singer MR, Nguyen Uyen-Sa DT, Mannino S, Milunsky A.Teratogenicity of high vitamin A intake. N Engl J Med 1995; 333: 1369-73.
7. Anbefalinger og virkemidler for økt folatinntak blant kvinner i fertil alder. Rapport nr. 1/98. Oslo: Statens ernaîringsrâd, 1998.
8. Kramer MS. Sosioeconomic determinants of intrauterine growth retardation. Eur J Clin Nutr 1998; 52 (suppl 1): 29-33.
9. Henriksen C, Brunvand L, Stoltenberg C, Trygg K, Haug E, Pedersen JI. Diet and vitamin D status among pregnant Pakistani women in Oslo. Eur J Clin Nutr 1995; 49: 211-8.
10. Neerhof MG. Causes of intrauterine growth restriction. Clin Perinatol 1995; 22: 375-84.
11. Crawford MA. The role of essential fatty acids in neural development: implications for perinatal nutrition. Am J Clin Nutr 1993; 57 (suppl): 703-10.
12. Villar J, Belizân JE. The relative contribution of prematurity and fetal growth to low birthweight in developing and developed societies. Am J Obstet Gynecol 1982; 143: 793-8.
13. Rutherford MA. Long-term outcomes of preterm infants. I: Elder MG, Romero R, Lamont RF, red. Preterm labor. New York: Churchill Livingstone, 1997: 517-37.
14. Bakketeig LS. Current growth standards, definitions, diagnosis and classification of fetal growth retardation. Eur J Clin Nutr 1998; 52 (suppl 1): 1-4.
15. Henriksen T, Clausen T. Intrauterin vekstretardsjon. Norsk Epidemiologi 1997; 7: 59-68.
16. Lockwood CJ. Weiner S. Assessment of fetal growth. Clin Perinatol 1986; 13: 3-35.
17. Goldenberg RL, Hoffmann HJ, Cliver SP. Neurodevelopmental outcome of small-for-gestational-age infants. Eur J Clin Nutr 1998; 52 (suppl 1): 54-8.
18. Vik T. Growth, morbidity, and psychomotor development in infants who were growth rearded in utero. Doktoravhandling. Trondheim: Norges teknisk-naturvitenskapelige université!, 1996.
19. Toft HS, Sabroe S, Olsen J, Rothman KJ, Gillman MW, Fischer P. Birthweight and cognitive function in young adult life: historical cohort study. BMJ 1997; 315: 401-3.
20. Øyen N, Skjrven R, Little R, Wolcox A. Fetal growth retardation in sudden death syndrome (SIDS) babies and their siblings. Am J Epidemiol 1995; 142: 84-90.
21. Henriksen T, Nakling J, Winge T, Leikanger K. Intrauterin veksthemning. I: . Dalaker K, red. Veileder i fiadselshjelp. Oslo: Den norske Icegeforening, 1998: 90-3.
22. Forsdahl A. Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic disease? Br J Prev Soc Med 1977; 31: 91-5.
23. Barker DJP, Osmond C. Infant mortality, childhood nutrition and ischémie heart disease in England and Wales. Lancet 1986; 1: 1077-81.
24. Kramer MS, Joseph KS. Enigma of fetal/infant-origins hypothesis. Lancet 1996; 348: 1254.
25. Law CM, Shiell AW. Is blood pressure inversely related to birth weight ? The strenght of evidence from systematic review of the literature. J Hypertens 1996; 14: 935-41.
26. Hanssens M, Scheldt P, Keirse M, Van Assche FA. Birthweight relates to risk of preeclampsia in later life. J Soc Gynecol Invest 1996; 3: 303A.
27. de Onis M, Villar J, Gülmeezoglu M. Nutritional interventions to prevent growth retardation: evidence from randomized controlled trials. Eur J Clin Nutr 1998; 52: (suppl 1): 83-93.
28. Cnattingius S, Berstrem R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 1998; 338: 147-52.
29. Intrauterin ernsering. Rapport nr. 5/1997. Oslo: Statens ernaeringsrâd. 1997.
30. Bulstra-Ramakers MTEW, Huisjes HJ, Visser GHA. The effects of 3 g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol 1994; 102: 123-6.
31. Sanchez-Ramos L, Adair CD, Kaunitz AM, Briones DK, Del Valle GO, Delke I. Calcium supplementation in mild preeclampsia remote from term: a randomized double-blind clinical trial. Obstet Gynecol 1995: 85: 915-8.
32. Ceesay SM, Prentice AM, Cole TJ, Foord F, Weaver LT, Poskitt EME et al. Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. BMJ 1997; 315: 786-90.
33. Moore SE, Cole TJ. Poskitt EM, Sonko BJ, Whitehead RG, McGregor IA et al. Season of birth predicts mortality in rural Gambia. Nature 1997; 388: 434.
34. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DO et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345: 149-51.
35. Molloy AM, Daly S, Mills JM, Kirke PN, Whitehead AS, Ramsbottom D et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997; 349: 1591-3.
36. Greene NDE, Copp AJ. Inositol prevents folate-resistent neural tube defects in the mouse. Nat Med 1997; 3: 60-6.